Standards & Regulation

A look at cGMP deviations in recent warning letters, including manufacturing conducted in corridors and equipment uncleaned for 14 years.

Is renting material handling equipment the best way to help manufacturers tackle waste?

US-based law and patenting experts offer their thoughts on IP protection in the digital age

I explore recent cases of pediatric cough medicines contaminated with diethylene glycol.

The EMA is reviewing whether certain Novo Nordisk drugs are linked to suicidal thoughts

Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price.

How do we prevent criminals from reusing primary packaging for counterfeit medicines? Labeling solutions and other creative concepts can help.

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Misbranded drugs, unapproved drugs, and companies who don’t know that ophthalmic drugs should be manufactured in a sterile environment…

Child exposure to pharmaceutical substances appears to be decreasing, but what more can packaging companies do to push the trend?